ER predicts poor prognosis in male lung squamous cell cancer of stage IIIA-N2 disease after sequential adjuvant chemoradiotherapy

INTRODUCTION: The efficacy of postoperative radiotherapy (PORT) is still unclear in non-small cell lung cancer (NSCLC) patients with pIIIA-N2 disease. Estrogen receptor (ER) was proven significantly associated with poor clinical outcome of male lung squamous cell cancer (LUSC) after R0 resection in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue, Wang, Lili, Jin, Xiangfeng, Xu, Rongjian, Yu, Zhuang, Li, Hongmei, Lu, Haijun, An, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176091/
https://www.ncbi.nlm.nih.gov/pubmed/37188197
http://dx.doi.org/10.3389/fonc.2023.1158104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176091/
https://www.ncbi.nlm.nih.gov/pubmed/37188197
http://dx.doi.org/10.3389/fonc.2023.1158104

Ejemplares similares